Table 2.
Baseline characteristics of the study population.
| Characteristic | |
|---|---|
| Age (years) | 64.6 ± 9.0 |
| Male | 15 (47.0) |
| Diabetes | 16 (50.0) |
| Dyslipidemia | 19 (59.4) |
| Hypertension | 27 (84.4) |
| Current smoking | 2 (6.3) |
| Former smoking | 8 (25.0) |
| Family history of CAD | 17 (53.1) |
| Prior myocardial infarction | 7 (21.9) |
| Prior PCI | 6 (18.8) |
| Prior CABG | 3 (9.4) |
| Cerebrovascular disease | 1 (3.1) |
| Peripheral vessel disease | 3 (9.4) |
| Medications | |
| Antiplatelet agents | 21 (66.7) |
| Beta-blockers | 27 (83.3) |
| ACEi/ARB | 5 (15.6) |
Numbers are n (%) or mean ± SD.
ACEi/ARB angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, CABG coronary artery bypass grafting, PCI percutaneous transluminal coronary angioplasty.